Evidence map›Paper›PMID 30778347›Full record

ArticleFrontiers in immunology2019

Humanized Mice Reveal New Insights Into the Thymic Selection of Human Autoreactive CD8

Yang Li, Nato Teteloshvili, Shulian Tan, Samhita Rao, Arnold Han, Yong-Guang Yang, Rémi J Creusot

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Humanized mouse models for immuno-oncology research.Nature reviews. Clinical oncology · 2023
    Review
  9. Article
  10. Review
  11. Allogeneic and xenogeneic lymphoid reconstitution in aFrontiers in veterinary science · 2022
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yang LiThe First Hospital of Jilin University, Changchun, China.
Nato TeteloshviliColumbia Center for Translational Immunology and Department of Medicine, Columbia University Medical Center, New York, NY, United States.
Shulian TanThe First Hospital of Jilin University, Changchun, China.
Samhita RaoColumbia Center for Translational Immunology and Department of Medicine, Columbia University Medical Center, New York, NY, United States.
Arnold HanColumbia Center for Translational Immunology and Department of Medicine, Columbia University Medical Center, New York, NY, United States.
Yong-Guang YangThe First Hospital of Jilin University, Changchun, China.
Rémi J CreusotColumbia Center for Translational Immunology and Department of Medicine, Columbia University Medical Center, New York, NY, United States.
Columbia University Irving Medical Center · USJilin International Studies University · CN

Funding

Translational Biomarker Analytical Core (TBAC)P30DK063608 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Anthony W Ferrante · 2003 to 2026
$36.7M
MECHANISMS OF BETA CELL FAILURER01DK064819 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ACCILI, DOMENICO · 2003 to 2025
$10.5M
BD Biosciences InfluxS10OD020056 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E · 2015 to 2015
$600k
Tolerance-inducing properties of human dendritic cell subsets in vivoR21AI117641 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CREUSOT, REMI J · 2015 to 2016
$440k
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
NCRR NIH HHS S10 RR027050NIAID NIH HHS R21 AI117641NIDDK NIH HHS P30 DK063608NIDDK NIH HHS R01 DK064819NIH HHS S10 OD020056
6 · The paper itself

Abstract

Thymic selection constitutes the first checkpoint in T-cell development to purge autoreactive T cells. Most of our understanding of this process comes from animal models because of the challenges of studying thymopoiesis and how T cell receptor (TCR) specificity impacts thymocyte phenotype in humans. We developed a humanized mouse model involving the introduction of autoreactive TCRs and cognate autoantigens that enables the analysis of selection of human T cells in human thymic tissue

Indexed as

AnimalsAntigen-Presenting CellsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFemaleHumansMaleMART-1 AntigenMiceMice, TransgenicThymectomyThymus GlandMART-1 Antigenantigen-presenting cellautoantigenautoreactiveclonal deletionhumanized mousehuman thymocyteT cell receptorthymic selection

Identifiers

PMID30778347
PMCPMC6369192
OpenAlexW2913739212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.